Suppr超能文献

与皮肤黑色素瘤局部和转移复发相关的危险因素。

Risk factors associated with local and in-transit recurrence of cutaneous melanoma.

机构信息

Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ 85054, USA.

出版信息

Am J Surg. 2010 Dec;200(6):770-4; discussion 774-5. doi: 10.1016/j.amjsurg.2010.07.025.

Abstract

BACKGROUND

Understanding the risk factors for local and in-transit recurrences (LR/ITR) may help facilitate methods of prevention, early detection, and treatment.

METHODS

A retrospective review of a prospectively collected database was performed on patients diagnosed with single-lesion cutaneous melanoma. Clinical and pathologic characteristics of the tumors were evaluated.

RESULTS

Of 225 patients, 10% had LR/ITR. Patients with LR/ITR were older (P = .0002), had thicker tumors (P = .018), and positive angiolymphatic invasion more frequently (P < .0001). An increased tumor mitotic rate (TMR) was more common in LR/ITRs (P = .051). On univariate logistic regression, age, thickness, TMR of 11/mm(2) or greater, and angiolymphatic invasion were all significant risk factors for LR/ITR. Multivariate logistic regression showed age, thickness, and angiolymphatic invasion were the only significant risk factors.

CONCLUSIONS

Older patients with thicker tumors and angiolymphatic invasion appear to be at higher risk for LR/ITR. Such patients warrant consideration of preventative strategies and should receive close clinical follow-up evaluation for early recurrence.

摘要

背景

了解局部和转移复发(LR/ITR)的风险因素有助于促进预防、早期发现和治疗方法的发展。

方法

对诊断为单发皮肤黑色素瘤的患者进行前瞻性收集数据库的回顾性分析。评估肿瘤的临床和病理特征。

结果

在 225 名患者中,10%发生 LR/ITR。发生 LR/ITR 的患者年龄更大(P=.0002),肿瘤更厚(P=.018),并且更常出现血管淋巴管侵犯(P<.0001)。LR/ITR 中更常见较高的肿瘤有丝分裂率(TMR)(P=.051)。单因素逻辑回归分析显示,年龄、厚度、TMR 为 11/mm(2)或更高,以及血管淋巴管侵犯都是 LR/ITR 的显著危险因素。多因素逻辑回归显示,年龄、厚度和血管淋巴管侵犯是唯一的显著危险因素。

结论

年龄较大、肿瘤较厚且有血管淋巴管侵犯的患者似乎有更高的 LR/ITR 风险。这些患者需要考虑预防策略,并应密切进行临床随访评估以早期发现复发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验